1-((4-METHYLQUINAZOLIN-2-YL)METHYL)-3-METHYL-7-(2-BUTIN-1-YL)-8-(3(R)-4-METHYLPHTHALIMIDOPIPERIDINE-YL)-XANTHINE
UNII 5X77FB3MA5
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-((4-methylquinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3(r)-4-methylphthalimidopiperidine-yl)-xanthine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5X77FB3MA5.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1573118-33-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C34H32N8O4 AGWYFWXRPWKTBR-JOCHJYFZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-((4-methylquinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3(r)-4-methylphthalimidopiperidine-yl)-xanthine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.